Darapladib CAS No.356057-34-6
Darapladib CAS No.356057-34-6
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1954 | 25mg | 400.00 | + Add to cart |
|
| R-R-1954 | 50mg | 670.00 | + Add to cart |
|
|
|
||||
Product description
Darapladib (SB-480848)/CAS No.356057-34-6 is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer.
| Appearance | N/A |
|---|---|
| Molecular Weight | 666.77 |
| Purity | >90% |
| CAS | 356057-34-6 |
| Formula | C36H38F4N4O2S |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Darapladib CAS No.356057-34-6
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


